LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
18378-0 | Transcortin | MCnc | Pt | CSF | Qn | null | CHEM | 1 | Transcortin [Mass/volume] in Cerebral spinal fluid | Transcortin CSF-mCnc | null | ACTIVE | 1.0l | 2.42 |
18379-8 | Urate | MRat | 6H | Urine | Qn | null | CHEM | 1 | Urate [Mass/time] in 6 hour Urine | Urate 6h Ur-mRate | null | ACTIVE | 1.0l | 2.42 |
18380-6 | Uroporphyrinogen decarboxylase | EntCat | Pt | RBC | Qn | null | CHEM | 1 | Uroporphyrinogen decarboxylase [Entitic Catalytic Activity] in Red Blood Cells | URO-D RBC Qn | null | ACTIVE | 1.0l | 2.73 |
18381-4 | Uroporphyrinogen decarboxylase | CCnc | Pt | Bld | Qn | null | CHEM | 1 | Uroporphyrinogen decarboxylase [Enzymatic activity/volume] in Blood | URO-D Bld-cCnc | null | ACTIVE | 1.0l | 2.68 |
1838-2 | Alpha-N-acetylglucosaminidase | CCnt | Pt | Tiss | Qn | null | CHEM | 1 | Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Tissue | A-NAG Tiss-cCnt | null | ACTIVE | 1.0 | 2.42 |
18382-2 | Specimen.dry weight | MRat | 24H | Stool | Qn | null | SPEC | 1 | Dry weight [Mass/time] of 24 hour Stool | Dry Spec Wt 24h Stl-mRate | null | ACTIVE | 1.0l | 2.73 |
18383-0 | Alfentanil | PrThr | Pt | Urine | Ord | null | DRUG/TOX | 1 | Alfentanil [Presence] in Urine | Alfentanil Ur Ql | null | ACTIVE | 1.0l | 2.56 |
18384-8 | Butabarbital | MCnc | Pt | Ser/Plas | Qn | Confirm | DRUG/TOX | 1 | Butabarbital [Mass/volume] in Serum or Plasma by Confirmatory method | Butabarbital SerPl Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
18385-5 | Butalbital | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Butalbital [Presence] in Urine by Confirmatory method | Butalbital Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
18386-3 | Chlorothiazide | PrThr | Pt | Ser/Plas | Ord | null | DRUG/TOX | 1 | Chlorothiazide [Presence] in Serum or Plasma | Chlorothiazide SerPl Ql | null | ACTIVE | 1.0l | 2.56 |
18387-1 | Diamorphine | MCnc | Pt | Ser/Plas | Qn | null | DRUG/TOX | 1 | Diamorphine [Mass/volume] in Serum or Plasma | DAM SerPl-mCnc | null | ACTIVE | 1.0l | 2.73 |
18388-9 | diazePAM | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | diazePAM [Presence] in Urine by Confirmatory method | diazePAM Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
18389-7 | Methaqualone | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Methaqualone [Presence] in Urine by Confirmatory method | Methaqualone Ur Ql Cfm | null | ACTIVE | 1.0l | 2.70 |
1839-0 | Ammonia | SCnc | Pt | Bld | Qn | null | CHEM | 1 | Ammonia [Moles/volume] in Blood | Ammonia Bld-sCnc | null | ACTIVE | 1.0 | 2.73 |
18390-5 | Opiates | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Opiates [Presence] in Urine by Confirmatory method | Opiates Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
18391-3 | Paraldehyde | MCnc | Pt | Urine | Qn | null | DRUG/TOX | 1 | Paraldehyde [Mass/volume] in Urine | Paraldehyde Ur-mCnc | null | ACTIVE | 1.0l | 2.42 |
18392-1 | Phencyclidine | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Phencyclidine [Presence] in Urine by Confirmatory method | PCP Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
18393-9 | quiNIDine+Quinine | PrThr | Pt | Urine | Ord | null | DRUG/TOX | 1 | quiNIDine+Quinine [Presence] in Urine | quiNIDine+Quinine Ur Ql | null | ACTIVE | 1.0l | 2.56 |
18394-7 | HLA-A24(9) | PrThr | Pt | Bld/Tiss | Ord | null | HLA | 1 | HLA-A24(9) [Presence] | HLA-A24(9) Ql | null | ACTIVE | 1.0l | 2.56 |
18395-4 | Aspergillus niger Ab | PrThr | Pt | CSF | Ord | null | MICRO | 1 | Aspergillus niger Ab [Presence] in Cerebral spinal fluid | A niger Ab CSF Ql | null | ACTIVE | 1.0l | 2.73 |
18396-2 | HIV 1 p24 Ag | PrThr | Pt | Ser/Plas | Ord | IA | MICRO | 1 | HIV 1 p24 Ag [Presence] in Serum or Plasma by Immunoassay | HIV1 p24 Ag SerPl Ql IA | null | ACTIVE | 1.0l | 2.73 |
18397-0 | Polio virus 1 Ab | Titr | Pt | CSF | Qn | Comp fix | MICRO | 1 | Polio virus 1 Ab [Titer] in Cerebral spinal fluid by Complement fixation | PV1 Ab Titr CSF CF | null | ACTIVE | 1.0l | 2.73 |
18398-8 | Polio virus 2 Ab | Titr | Pt | CSF | Qn | Comp fix | MICRO | 1 | Polio virus 2 Ab [Titer] in Cerebral spinal fluid by Complement fixation | PV2 Ab Titr CSF CF | null | ACTIVE | 1.0l | 2.73 |
18399-6 | Polio virus 3 Ab | Titr | Pt | CSF | Qn | Comp fix | MICRO | 1 | Polio virus 3 Ab [Titer] in Cerebral spinal fluid by Complement fixation | PV3 Ab Titr CSF CF | null | ACTIVE | 1.0l | 2.73 |
18400-2 | Spermatozoa Ab.IgA | ACnc | Pt | Cvm | Qn | null | FERT | 1 | Spermatozoa IgA Ab [Units/volume] in Cervical mucus | Sperm IgA Cerv mucus-aCnc | null | ACTIVE | 1.0l | 2.69 |
18401-0 | Spermatozoa Ab.IgG | ACnc | Pt | Cvm | Qn | null | FERT | 1 | Spermatozoa IgG Ab [Units/volume] in Cervical mucus | Sperm IgG Cerv mucus-aCnc | null | ACTIVE | 1.0l | 2.69 |
18402-8 | Spermatozoa Ab.IgA | ACnc | Pt | Semen | Qn | null | FERT | 1 | Spermatozoa IgA Ab [Units/volume] in Semen | Sperm IgA Smn-aCnc | null | ACTIVE | 1.0l | 2.73 |
18403-6 | Spermatozoa Ab.IgG | ACnc | Pt | Semen | Qn | null | FERT | 1 | Spermatozoa IgG Ab [Units/volume] in Semen | Sperm IgG Smn-aCnc | null | ACTIVE | 1.0l | 2.73 |
18404-4 | Spermatozoa Ab.IgM | ACnc | Pt | Semen | Qn | null | FERT | 1 | Spermatozoa IgM Ab [Units/volume] in Semen | Sperm IgM Smn-aCnc | null | ACTIVE | 1.0l | 2.73 |
18405-1 | Arsenate | MCnc | Pt | Urine | Qn | null | DRUG/TOX | 1 | Arsenate [Mass/volume] in Urine | Arsenate Ur-mCnc | null | ACTIVE | 1.0l | 2.42 |
18406-9 | Arsenic trioxide | MCnc | Pt | Urine | Qn | null | DRUG/TOX | 1 | Arsenic trioxide [Mass/volume] in Urine | Arsenic trioxide Ur-mCnc | null | ACTIVE | 1.0l | 2.42 |
18407-7 | Leukocytes | NRat | 12H | Urine sed | Qn | Microscopy.light | UA | 1 | Leukocytes in 12 hour Urine sediment by Light microscopy | WBC 12h UrnS Micro-nRate | null | ACTIVE | 1.0l | 2.27 |
1840-8 | Ammonia | SCnc | Pt | CSF | Qn | null | CHEM | 1 | Ammonia [Moles/volume] in Cerebral spinal fluid | Ammonia CSF-sCnc | null | ACTIVE | 1.0 | 2.73 |
18408-5 | Cells.CD3+HLA-DR+/100 cells | NFr | Pt | Bld | Qn | null | CELLMARK | 1 | CD3+HLA-DR+ cells/100 cells in Blood | CD3+HLA-DR+ Cells NFr Bld | null | ACTIVE | 1.0l | 2.73 |
18409-3 | Curvularia lunata Ab.IgG | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Curvularia lunata IgG Ab [Units/volume] in Serum | C lunata IgG Qn | null | ACTIVE | 1.0l | 2.73 |
18410-1 | Epicoccum purpurascens Ab.IgG | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Epicoccum purpurascens IgG Ab [Units/volume] in Serum | E purpurascens IgG Qn | null | ACTIVE | 1.0l | 2.73 |
18411-9 | Rhizopus nigricans Ab.IgG | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Rhizopus nigricans IgG Ab [Units/volume] in Serum | R nigricans IgG Qn | null | ACTIVE | 1.0l | 2.73 |
18412-7 | Stemphylium botryosum Ab.IgG | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Stemphylium botryosum IgG Ab [Units/volume] in Serum | S botryosum IgG Qn | null | ACTIVE | 1.0l | 2.73 |
18413-5 | HLA-DR16 | PrThr | Pt | Bld/Tiss | Ord | null | HLA | 1 | HLA-DR16 [Presence] | HLA-DR16 Ql | null | ACTIVE | 1.0l | 2.73 |
18414-3 | Psilocin | PrThr | Pt | Urine | Ord | null | DRUG/TOX | 1 | Psilocin [Presence] in Urine | Psilocin Ur Ql | null | ACTIVE | 1.0l | 2.73 |
18415-0 | Psilocin | MCnc | Pt | Urine | Qn | null | DRUG/TOX | 1 | Psilocin [Mass/volume] in Urine | Psilocin Ur-mCnc | null | ACTIVE | 1.0l | 2.73 |
1841-6 | Ammonia | SCnc | Pt | Ser | Qn | null | CHEM | 1 | Ammonia [Moles/volume] in Serum | Ammonia Ser-sCnc | null | DISCOURAGED | 1.0 | 2.73 |
18416-8 | Aspergillus nidulans Ab.IgG | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Aspergillus nidulans IgG Ab [Units/volume] in Serum | A nidulans IgG Qn | null | ACTIVE | 1.0l | 2.73 |
18417-6 | Bean black Ab.IgG | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Black Bean IgG Ab [Units/volume] in Serum | Black Bean IgG Qn | null | ACTIVE | 1.0l | 2.69 |
18418-4 | Casein Ab.IgA | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Casein IgA Ab [Units/volume] in Serum | Casein IgA Qn | null | ACTIVE | 1.0l | 2.69 |
18419-2 | Cephalosporine mold Ab.IgG | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Cephalosporine mold IgG Ab [Units/volume] in Serum | Cephalospor Mold IgG Qn | null | ACTIVE | 1.0l | 2.73 |
184-2 | Ciprofloxacin | Susc | Pt | Isolate | Qn | MLC | ABXBACT | 1 | Ciprofloxacin [Susceptibility] by Minimum lethal concentration (MLC) | Ciprofloxacin Islt MLC | null | ACTIVE | 1.0 | 2.19 |
18420-0 | Chaetomium globosum Ab.IgG | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Chaetomium globosum IgG Ab [Units/volume] in Serum | C globosum IgG Qn | null | ACTIVE | 1.0l | 2.73 |
18421-8 | Fusarium oxysporum Ab.IgG | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Fusarium oxysporum IgG Ab [Units/volume] in Serum | F oxysporum IgG Qn | null | ACTIVE | 1.0l | 2.73 |
18422-6 | Microcytes | PrThr | Pt | Urine | Ord | Microscopy.light | HEM/BC | 1 | Microcytes [Presence] in Urine by Light microscopy | Microcytes Ur Ql Micro | null | ACTIVE | 1.0l | 2.73 |
18423-4 | Phthalic anhydride Ab.IgG | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Phthalic anhydride IgG Ab [Units/volume] in Serum | PAN IgG Qn | null | ACTIVE | 1.0l | 2.69 |
1842-4 | Ammonia | SCnc | Pt | Urine | Qn | null | CHEM | 1 | Ammonia [Moles/volume] in Urine | Ammonia Ur-sCnc | null | ACTIVE | 1.0 | 2.73 |
18424-2 | Phthalic anhydride Ab.IgM | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Phthalic anhydride IgM Ab [Units/volume] in Serum | PAN IgM Qn | null | ACTIVE | 1.0l | 2.69 |
18425-9 | Squash zucchini Ab.IgG | ACnc | Pt | Ser | Qn | null | ALLERGY | 1 | Zucchini IgG Ab [Units/volume] in Serum | Zucchini IgG Qn | null | ACTIVE | 1.0l | 2.73 |
18426-7 | Aspergillus sp Ab | PrThr | Pt | CSF | Ord | null | MICRO | 1 | Aspergillus sp Ab [Presence] in Cerebral spinal fluid | Aspergillus Ab CSF Ql | null | ACTIVE | 1.0l | 2.56 |
18427-5 | Epstein Barr virus early Ab | PrThr | Pt | Body fld | Ord | null | MICRO | 1 | Epstein Barr virus early Ab [Presence] in Body fluid | EBV EA Ab Fld Ql | null | ACTIVE | 1.0l | 2.56 |
18428-3 | Epstein Barr virus nuclear Ab.IgG | PrThr | Pt | CSF | Ord | null | MICRO | 1 | Epstein Barr virus nuclear IgG Ab [Presence] in Cerebral spinal fluid | EBV NA IgG CSF Ql | null | ACTIVE | 1.0l | 2.56 |
18429-1 | Rickettsia rickettsii Ab.IgG | ACnc | Pt | CSF | Qn | null | MICRO | 1 | Rickettsia rickettsii IgG Ab [Units/volume] in Cerebral spinal fluid | R rickettsi IgG CSF-aCnc | null | ACTIVE | 1.0l | 2.69 |
18430-9 | Rickettsia rickettsii Ab.IgM | ACnc | Pt | CSF | Qn | null | MICRO | 1 | Rickettsia rickettsii IgM Ab [Units/volume] in Cerebral spinal fluid | R rickettsi IgM CSF-aCnc | null | ACTIVE | 1.0l | 2.69 |
18431-7 | Amphetamines | PrThr | Pt | Stool | Ord | Screen | DRUG/TOX | 1 | Amphetamines [Presence] in Stool by Screen method | Amphetamines Stl Ql Scn | null | ACTIVE | 1.0l | 2.56 |
1843-2 | Ammonia nitrogen | MRat | 24H | Urine | Qn | null | CHEM | 1 | Ammonia nitrogen [Mass/time] in 24 hour Urine | Ammonia nitrogen 24h Ur-mRate | null | ACTIVE | 1.0 | 2.73 |
18432-5 | Tetrahydrocannabinol | PrThr | Pt | Stool | Ord | Screen | DRUG/TOX | 1 | Tetrahydrocannabinol [Presence] in Stool by Screen method | THC Stl Ql Scn | null | ACTIVE | 1.0l | 2.56 |
18433-3 | 1,3-Dichlorobenzene | MCnc | Pt | Bld | Qn | null | DRUG/TOX | 1 | Deprecated 1,3-Dichlorobenzene [Mass/volume] in Blood | Deprecated 1,3DCB Bld-mCnc | null | DEPRECATED | 1.0l | 2.36 |
18434-1 | 1,2-Dichlorobenzene | MCnc | Pt | Bld | Qn | null | DRUG/TOX | 1 | 1,2-Dichlorobenzene [Mass/volume] in Blood | 1,2DCB Bld-mCnc | null | ACTIVE | 1.0l | 2.73 |
18435-8 | SUFentanil | PrThr | Pt | Urine | Ord | null | DRUG/TOX | 1 | SUFentanil [Presence] in Urine | SUFentanil Ur Ql | null | ACTIVE | 1.0l | 2.56 |
18436-6 | Acetylcarnitine (C2) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Acetylcarnitine (C2) [Mass/volume] in Serum or Plasma | Acetylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18437-4 | Acrylylcarnitine (C3:1) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Acrylylcarnitine (C3:1) [Mass/volume] in Serum or Plasma | Acrylylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18438-2 | Propionylcarnitine (C3) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Propionylcarnitine (C3) [Mass/volume] in Serum or Plasma | Propionylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18439-0 | Butyrylcarnitine (C4) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Butyrylcarnitine (C4) [Mass/volume] in Serum or Plasma | Butyrylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
1844-0 | Ammonium ion | SCnc | Pt | BldA | Qn | null | CHEM | 1 | Ammonium ion [Moles/volume] in Arterial blood | Ammonium Ion BldA-sCnc | null | ACTIVE | 1.0 | 2.42 |
18440-8 | Crotonylcarnitine (C4:1) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Crotonylcarnitine (C4:1) [Mass/volume] in Serum or Plasma | Crotonylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.42 |
18441-6 | Isovalerylcarnitine (C5) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Isovalerylcarnitine (C5) [Mass/volume] in Serum or Plasma | Isovalerylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18442-4 | 3-Hydroxybutyrylcarnitine (C4-OH) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | 3-Hydroxybutyrylcarnitine (C4-OH) [Mass/volume] in Serum or Plasma | 3OH-Butyrcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18443-2 | Hexanoylcarnitine (C6) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Hexanoylcarnitine (C6) [Mass/volume] in Serum or Plasma | Hexanoylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18444-0 | 3-Hydroxyisovalerylcarnitine (C5-OH) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | 3-Hydroxyisovalerylcarnitine (C5-OH) [Mass/volume] in Serum or Plasma | 3OH-Isovalerylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18445-7 | Benzoylcarnitine (BzCn) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Benzoylcarnitine (BzCn) [Mass/volume] in Serum or Plasma | Benzoylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18446-5 | Methylmalonylcarnitine (C4-DC) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Methylmalonylcarnitine (C4-DC) [Mass/volume] in Serum or Plasma | Me-malonylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18447-3 | Octenoylcarnitine (C8:1) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Octenoylcarnitine (C8:1) [Mass/volume] in Serum or Plasma | Octenoylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18448-1 | Octanoylcarnitine (C8) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Octanoylcarnitine (C8) [Mass/volume] in Serum or Plasma | Octanoylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18449-9 | Glutarylcarnitine (C5-DC) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Glutarylcarnitine (C5-DC) [Mass/volume] in Serum or Plasma | Glutarylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18450-7 | Adipoylcarnitine (C6-DC) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Adipoylcarnitine (C6-DC) [Mass/volume] in Serum or Plasma | Adipoylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18451-5 | Cis-4-decenoylcarnitine (Cis 4 C10:1) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | cis-4-Decenoylcarnitine (Cis 4 C10:1) [Mass/volume] in Serum or Plasma | Cis4Decenoylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.42 |
18452-3 | Decanoylcarnitine (C10) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Decanoylcarnitine (C10) [Mass/volume] in Serum or Plasma | Decanoylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18453-1 | Suberylcarnitine (C8-DC) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Suberylcarnitine (C8-DC) [Mass/volume] in Serum or Plasma | Suberylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18454-9 | Dodecenoylcarnitine (C12:1) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Dodecenoylcarnitine (C12:1) [Mass/volume] in Serum or Plasma | Dodecenoylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18455-6 | Dodecanoylcarnitine (C12) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Dodecanoylcarnitine (C12) [Mass/volume] in Serum or Plasma | Dodecanoylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18456-4 | Tetradecadienoylcarnitine (C14:2) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Tetradecadienoylcarnitine (C14:2) [Mass/volume] in Serum or Plasma | Tdecadienoylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
1845-7 | Ammonium ion | SCnc | Pt | Plas | Qn | null | CHEM | 1 | Ammonium ion [Moles/volume] in Plasma | Ammonium Ion Plas-sCnc | null | ACTIVE | 1.0 | 2.34 |
18457-2 | Tetradecenoylcarnitine (C14:1) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Tetradecenoylcarnitine (C14:1) [Mass/volume] in Serum or Plasma | Tdecenoylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18458-0 | 3-Hydroxytetradecadienoylcarnitine (C14:2-OH) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | 3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Mass/volume] in Serum or Plasma | 3OH-Tdecadienoylcar SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.42 |
18459-8 | 3-Hydroxytetradecenoylcarnitine (C14:1-OH) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | 3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Mass/volume] in Serum or Plasma | 3OH-Tdecenoylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18460-6 | Palmitoylcarnitine (C16) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Palmitoylcarnitine (C16) [Mass/volume] in Serum or Plasma | Palmitoylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18461-4 | 3-Hydroxypalmitoylcarnitine (C16-OH) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | 3-Hydroxypalmitoylcarnitine (C16-OH) [Mass/volume] in Serum or Plasma | 3OH-Palmitoylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18462-2 | Linoleoylcarnitine (C18:2) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Linoleoylcarnitine (C18:2) [Mass/volume] in Serum or Plasma | Linoleoylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18463-0 | Oleoylcarnitine (C18:1) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Oleoylcarnitine (C18:1) [Mass/volume] in Serum or Plasma | Oleoylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18464-8 | 3-Hydroxylinoleoylcarnitine (C18:2-OH) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | 3-Hydroxylinoleoylcarnitine (C18:2-OH) [Mass/volume] in Serum or Plasma | 3OH-Linoleoylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
1846-5 | Amylo-alpha-1,6-glucosidase | CCnc | Pt | RBC | Qn | null | CHEM | 1 | Amylo-alpha-1,6-glucosidase [Enzymatic activity/volume] in Red Blood Cells | AGL RBC-cCnc | null | ACTIVE | 1.0 | 2.54 |
18465-5 | 3-Hydroxyoleoylcarnitine (C18:1-OH) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | 3-Hydroxyoleoylcarnitine (C18:1-OH) [Mass/volume] in Serum or Plasma | 3OH-Oleoylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18466-3 | Dicarboxyoleylcarnitine (C18:1-DC) | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Dicarboxyoleylcarnitine (C18:1-DC) [Mass/volume] in Serum or Plasma | Dicarboxyoleylcarn SerPl-mCnc | null | DISCOURAGED | 1.0l | 2.73 |
18467-1 | Venlafaxine | MCnc | Pt | Urine | Qn | null | DRUG/TOX | 1 | Venlafaxine [Mass/volume] in Urine | Venlafaxine Ur-mCnc | null | ACTIVE | 1.0l | 2.73 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.